Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Gerresheimer Aktie 3138496 / DE000A0LD6E6

28.08.2025 09:30:03

EQS-News: Gerresheimer expands financial flexibility to implement growth strategy

EQS-News: Gerresheimer AG / Key word(s): Financing
Gerresheimer expands financial flexibility to implement growth strategy

28.08.2025 / 09:30 CET/CEST
The issuer is solely responsible for the content of this announcement.


Gerresheimer expands financial flexibility to implement growth strategy

  • Loans of EUR 200 million to repay part of the bridge financing for the acquisition of Bormioli Pharma ahead of schedule
  • Expansion of flexibility in key contractual terms

Duesseldorf, August 28, 2025. Gerresheimer, an innovative system and solution provider and global partner to the pharma, biotech, and cosmetics industries, will prematurely repay part of the bridge financing for the acquisition of Bormioli Pharma with two loans totaling EUR 200 million from BayernLB and Landesbank Hessen-Thüringen. At the same time, certain key terms of the existing revolving credit facility of EUR 675 million and the remaining bridge financing of around EUR 525 million have been adjusted to provide greater flexibility. Gerresheimer has thus optimized the maturity profile of its corporate financing and increased its flexibility to implement its growth strategy as planned.

“Our corporate financing is solid, predictable in the long term, and flexible,” said Dietmar Siemssen, CEO of Gerresheimer AG. “We have the necessary financial headroom to continue driving forward our strategy with selective growth investments and a focus on free cash flow as planned.”

Optimized maturity profile of corporate financing

With the two loans of EUR 100 million each at market terms from BayernLB and Landesbank Hessen-Thüringen, Gerresheimer is replacing part of the bridge financing concluded in fall 2024 for the acquisition of the Bormioli Pharma Group. The company had already extended the bridge financing until September 2027 in May 2025. The optimized maturity profile and more flexible terms give Gerresheimer room for maneuver in its next strategic steps.

Financial headroom for implementing the corporate strategy

Gerresheimer will continue to invest selectively in margin-enhancing growth projects as part of its corporate strategy and is aiming for positive free cash flow in 2026.

 

About Gerresheimer 
Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The Group offers a comprehensive portfolio of drug containment solutions including closures and accessories, as well as drug delivery systems, medical devices and solutions for the health industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, cartridges, ampoules, tablet containers, infusion, dropper and syrup bottles and more. Gerresheimer ensures the safe delivery and reliable administration of drugs to the patient. Gerresheimer supports its customers with comprehensive services along the value chain and in addressing the growing demand for enhanced sustainability. With over 40 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets. Together with Bormioli Pharma, the Group generated revenues of around EUR 2.4bn in 2024 and currently employs around 13,600 people. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).    
www.gerresheimer.com 


Contact Gerresheimer AG

Media  
Jutta Lorberg
Head of Corporate Communication
T +49 211 6181 264
jutta.lorberg@gerresheimer.com                                           
Marion Stolzenwald
Senior Manager Corporate Communication
T +49 172 2424185
marion.stolzenwald@gerresheimer.com
 
Investor Relations
 
Guido Pickert
Vice President Investor Relations
T +49 211 6181 220
gerresheimer.ir@gerresheimer.com
 
Thomas Rosenke
Senior Manager Investor Relations
T +49 211 6181-187
gerresheimer.ir@gerresheimer.com


28.08.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Gerresheimer AG
Peter-Müller-Str. 3
40468 Duesseldorf
Germany
Phone: +49-(0)211/61 81-00
Fax: +49-(0)211/61 81-121
E-mail: gerresheimer.ir@gerresheimer.com
Internet: http://www.gerresheimer.com
ISIN: DE000A0LD6E6
WKN: A0LD6E
Indices: MDAX (Aktie)
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2189816

 
End of News EQS News Service

2189816  28.08.2025 CET/CEST

Analysen zu Gerresheimer AG

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
25.09.25 Gerresheimer Buy Hauck Aufhäuser Lampe Privatbank AG
25.09.25 Gerresheimer Hold Deutsche Bank AG
24.09.25 Gerresheimer Halten DZ BANK
24.09.25 Gerresheimer Overweight Barclays Capital
23.09.25 Gerresheimer Overweight JP Morgan Chase & Co.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Börsentag 2025: Silber vor Verdopplung? Rohstoffexperte über die Chancen

Im Experteninterview erklärt Prof. Dr. Torsten Dennin, welche Faktoren die Preise von Gold, Silber, Kupfer, Uran und Agrarrohstoffen treiben – und welche Chancen & Risiken Anleger jetzt kennen sollten.

👉 Was steckt hinter der aktuellen Gold- und Silber-Rallye?
👉 Welche Rohstoffe gelten 2025 als besonders spannend für Investments?
👉 Wie investieren Anlegerinnen und Anleger am besten in Edelmetalle & Rohstoffe?

Erhalte fundierte Einschätzungen, Marktprognosen und Antworten auf spannende Zuschauerfragen rund um Edelmetalle, Minenaktien, ETFs und Rohstofftrends.

Ein besonderes Highlight auf dem diesjährigen Börsentag Zürich war die BX Swiss Blogger-Lounge. Bekannte YouTuber und Finanz-Influencer standen für Gespräche und Diskussionen bereit und vermittelten Ihr Wissen und Ihre Erfahrungen in Vorträgen.

👉🏽 Jetzt auch auf BXplus anmelden und von exklusiven Inhalten rund um Investment & Trading profitieren!

Silber vor Verdopplung? Rohstoffexperte über die Chancen | Börsentag Zürich 2025

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’423.55 19.24 B26SWU
Short 12’680.06 13.71 BHDSPU
Short 13’137.38 8.97 UEBSLU
SMI-Kurs: 11’929.80 26.09.2025 17:31:16
Long 11’412.74 18.93 BK5S8U
Long 11’178.98 13.87 B3TS7U
Long 10’684.64 8.77 SSPM4U
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}